Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Thailand
/
Pharmaceuticals & Biotech
/
Mega Lifesciences
MEGA
Mega Lifesciences
Aging Populations And Emerging Markets Will Drive Wellness Demand
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
15 Jul 25
Updated
08 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
฿39.00
21.8% undervalued
intrinsic discount
08 Aug
฿30.50
Loading
1Y
-19.2%
7D
0%
Author's Valuation
฿39.0
21.8% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
฿39.0
21.8% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
17b
2014
2017
2020
2023
2025
2026
2028
Revenue ฿17.3b
Earnings ฿2.8b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
2.30%
Pharma revenue growth rate
1.00%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.42%
Calculation
฿2.79b
Earnings '28
x
15.09x
PE Ratio '28
=
฿42.10b
Market Cap '28
฿42.10b
Market Cap '28
/
871.87m
No. shares '28
=
฿48.29
Share Price '28
฿48.29
Share Price '28
Discounted to 2025 @ 7.42% p.a.
=
฿38.96
Fair Value '25